To OTC Journal Members:
 

A Look At the Future

Flip on the financial channels right now all you will get the biggest smorgasbord of conflicting viewpoints on the stock market and the economy I have ever experienced in the 22 years I have been investing in the markets. I can remember when CNBC was FNN (Financial News Network) - that's about when cable got rolling.

Let me clear it up a little for you. Here's a few givens: We are in a Bear Market, which means you have to buy stocks right, and buy the right stocks. You won't make money by accident. We are in a recession no matter what our President says. Ask anyone in the building trades- they will tell you we have been in a recession for some time. The market is going through a bottoming phase right now. Stocks will start behaving better six months before economic stats indicate we are coming out of the recession. These kinds of cycles are both normal and healthy. There will be new leadership in the next Bull Market (I'm thinking Green and Emerging Markets). We've been in a Bear market since early November, so we are not far away from the correction running its course.

The confusing rhetoric out of the financial pundits is really quite amusing. Recently, I stumbled on a list of predictions from some of the greatest minds of their particular generations. Here's a couple of classic prognostications from very educated and believable "best of breed" guys of their time. I believe you will find them amusing.

Here's one that's both stock market related and very enlightening if you believe all economists know what they're talking about:
 

As it turned out, for the next few years, Professor Fisher was right. The problem- the word "Permanently", as we all know the only constant is change, and the stock market was the best single asset class for returns in the 20th Century. Another genius economist.

Here's another beauty that's particularly funny as one considers the current state of the world wide oil market:
 

Imagine is these guys who used to drill for water in the mid 1800'2 had evolved over into oil drillers and kept going into the 20th Century? Not a bad business to leave your family rolling into the 20th Century.

I have a bunch more of these to share with you over time. No matter how smart you are, the winds of change will always blow in unpredictable and exciting directions.

Faith is often defined as "Belief in the Absence of Data". Have a little faith. Stocks are behaving poorly, but lots of companies are behaving pretty well. And, speaking of the winds of change:
 

It's been a while since I've delivered a new microcap idea. I've been content to simply continue updating the quality ideas that have survived the bear market and are delivering robust enough results to have a whole new leg up in the next Bull Market.

There's a new idea coming up in the next week or two. I am moving forward in unfavorable market conditions because this company is about to undergone a major transformation to the positive which should result in strong growth on both the top and bottom lines. 

Another unique feature- this "hybrid" idea features a combination of disciplines, which, when added up, but for a very robust growth picture. This company should deliver substantial growth in a $10 billion industry where the largest player only has 3% market share. 

And yes- there's a video with yours truly. I have them photoshopping in more hair and less stomach. They told me they were graphic designers, not miracle workers. Go figure.
 

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

(Insert specific company compensation here)

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.